Evidence map›Paper›PMID 38017020›Full record

ArticleScientific reports2023

Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes.

Guangliang Duan, Changxin Huang, Jiangang Zhao, Yinghong Zhang, Wenbin Zhao, Huiping Dai

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Guangliang DuanDepartment of Oncology, Hangzhou Normal University, Affiliated Hospital, Hangzhou, 310015, Zhejiang, China.
Changxin HuangDepartment of Oncology, Hangzhou Normal University, Affiliated Hospital, Hangzhou, 310015, Zhejiang, China.
Jiangang ZhaoDepartment of Oncology, Shaoxing Cent Hospital, Shaoxing, 312030, Zhejiang, China.
Yinghong ZhangDepartment of Nephrol, Hangzhou Normal University, Affiliated Hospital, Hangzhou, 310015, Zhejiang, China.
Wenbin ZhaoHangzhou Normal University Affiliated Hospital, Hangzhou, 310015, Zhejiang, China.
Huiping DaiDepartment of Proctol, Hangzhou Normal University, Affiliated Hospital, Hangzhou, 310015, Zhejiang, China. dhp20221316@hznu.edu.cn.
Affiliated Hospital of Hangzhou Normal University · CNShaoxing People's Hospital · CN

Funding

Zhejiang Traditional Chinese Medicine Scientific Research Fund Project NO.2018ZA099
6 · The paper itself

Abstract

Lung adenocarcinoma (LUAD) is one of the most widespread and fatal types of lung cancer. Oxidative stress, resulting from an imbalance in the production and accumulation of reactive oxygen species (ROS), is considered a promising therapeutic target for cancer treatment. Currently, immune checkpoint blockade (ICB) therapy is being explored as a potentially effective treatment for early-stage LUAD. In this research, we aim to identify distinct subtypes of LUAD patients by investigating genes associated with oxidative stress and immunotherapy. Additionally, we aim to propose subtype-specific therapeutic strategies. We conducted a thorough search of the Gene Expression Omnibus (GEO) datasets. From this search, we pinpointed datasets that contained both expression data and survival information. We selected genes associated with oxidative stress and immunotherapy using keyword searches on GeneCards. We then combined expression data of LUAD samples from both The Cancer Genome Atlas (TCGA) and 11 GEO datasets, forming a unified dataset. This dataset was subsequently divided into two subsets, Dataset_Training and Dataset_Testing, using a random bifurcation method, with each subset containing 50% of the data. We applied consensus clustering (CC) analysis to identify distinct LUAD subtypes within the Dataset_Training. Molecular variances associated with oxidative stress levels, the tumor microenvironment (TME), and immune checkpoint genes (ICGs) were then investigated among these subtypes. Employing feature selection combined with machine learning techniques, we constructed models that achieved the highest accuracy levels. We validated the identified subtypes and models from Dataset_Training using Dataset_Testing. A hub gene with the highest importance values in the machine learning model was identified. We then utilized virtual screening to discover potential compounds targeting this hub gene. In the unified dataset, we integrated 2,154 LUAD samples from TCGA-LUAD and 11 GEO datasets. We specifically selected 1,311 genes associated with immune and oxidative stress processes. The expression data of these genes were then employed for subtype identification through CC analysis. Within Dataset_Training, two distinct subtypes emerged, each marked by different levels of immune and oxidative stress pathway values. Consequently, we named these as the OX

Indexed as

Adenocarcinoma of LungLung NeoplasmsHumansImmunotherapyOxidative StressRadioimmunotherapyTumor Microenvironment

Identifiers

PMID38017020
PMCPMC10684862
OpenAlexW4389074942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.